$272.32
-4.00 (-1.45%)
As of Nov 5, 9:30 PM ET ·
Analyst Consensus
Buy
30
Analysts
Very High
Coverage
Buy 22 73%
Hold 8 27%
Sell 0 0%
Price Target
Analyst Price Target +10.0% upside
Low Target $223.02
Average Target $299.55
High Target $400.15
Current Price $272.32
Current
$272.32
Target
$299.55
$223.02 $299.55 avg $400.15
Scenario Analysis
Bear Case
$223.02
-18.1%
Low target
Base Case
$299.55
+10.0%
Avg target
Bull Case
$400.15
+46.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$281.07
-3.1% from high
52-Week Low
$184.66
+47.5% from low
50-Day SMA
$265.53
+2.6% vs SMA
200-Day SMA
$247.77
+9.9% vs SMA
RSI (14)
70.8
Overbought
Target vs 52W High
$299.55
+6.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%